Can an intra‑aortic balloon pump be inserted simultaneously with an Impella device?

Can IABP Be Inserted Simultaneously with Impella?

Yes, IABP can be inserted simultaneously with Impella, and this combination is explicitly recognized in current guidelines as a left ventricular venting strategy when using VA-ECMO, though recent evidence strongly suggests avoiding this combination in routine practice due to significant risks without proven mortality benefit.

Guideline-Supported Scenarios

The 2021 AHA Scientific Statement on cardiogenic shock explicitly lists IABP as one option for LV decompression when VA-ECMO is used, alongside Impella devices 1. This represents the primary guideline-endorsed indication for combining these devices—specifically to prevent LV distension and pulmonary edema when VA-ECMO increases afterload.

Critical Evidence Against Routine Combined Use

The 2024 Systematic Review Findings

The most recent and comprehensive evidence (2024) strongly recommends against combining IABP with Impella in routine clinical practice 2. This systematic review identified critical problems:

• 30-40% reduction in Impella flow when IABP is added, compromising the primary benefit of the Impella device
• Increased bleeding risk from dual arterial access
• Impella displacement risk from IABP pulsations
• Frequent positioning and pressure alarms requiring constant troubleshooting
• No mortality benefit compared to either device alone
• Inconclusive hemolysis data raising additional safety concerns

Theoretical vs. Clinical Reality

While the combination theoretically reduces myocardial oxygen demand/supply ratio without significantly altering LV work 2, these physiologic benefits have not translated into improved clinical outcomes. The observational case reports from 2009-2014 3, 4, 5 describing "successful" combined use predate our understanding of the significant complications this strategy creates.

Practical Algorithm for Device Selection

For predominant LV failure in cardiogenic shock:

• Choose either IABP or Impella based on degree of support needed 1
• IABP: Less invasive, lower flow augmentation
• Impella: Greater hemodynamic support (2.5-5.5 L/min depending on model)

For VA-ECMO with LV distension:

• IABP may be added as a venting strategy 1
• Impella is preferred for more effective LV unloading
• Pulmonary artery cannulation or surgical venting are alternatives

For biventricular failure:

• Use bilateral Impella pumps 1
• Not IABP + Impella combination

Common Pitfalls to Avoid

1. Don't add IABP to "boost" an inadequate Impella—if Impella flow is insufficient, upsize the Impella (2.5→5.0) or consider alternative MCS strategies rather than adding IABP
2. Don't assume additive benefits—the devices interfere mechanically and hemodynamically
3. Recognize alarm fatigue—the combination triggers frequent device alarms that may desensitize staff to genuine problems
4. Monitor for hemolysis aggressively if combination is unavoidable

Bottom Line

While technically feasible and mentioned in guidelines for specific VA-ECMO scenarios, the combination of IABP with Impella should be avoided in routine practice based on the strongest recent evidence 2. When greater support than IABP alone is needed, transition to Impella or other advanced MCS rather than combining devices. The only reasonable contemporary indication is LV venting during VA-ECMO when Impella alone is insufficient or unavailable.